164
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Glycosylation pattern and axin expression in normal and IUGR placentae

, , , , , , & show all
Pages 558-563 | Received 03 Jan 2014, Accepted 17 May 2014, Published online: 18 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jasenka Zmijanac Partl, Valentina Karin, Anita Skrtic, Tamara Nikuseva-Martic, Alan Serman, Jelena Mlinarec, Mirna Curkovic-Perica, Semir Vranic & Ljiljana Serman. (2018) Negative regulators of Wnt signaling pathway SFRP1 and SFRP3 expression in preterm and term pathologic placentas. The Journal of Maternal-Fetal & Neonatal Medicine 31:22, pages 2971-2979.
Read now

Articles from other publishers (2)

Mirian Mendoza, Dongli Lu, Angela Ballesteros, Sandra M Blois, Kelsey Abernathy, Chiguang Feng, Charles J Dimitroff, Jonathan Zmuda, Maria Panico, Anne Dell, Gerardo R Vasta, Stuart M Haslam & Gabriela Dveksler. (2020) Glycan characterization of pregnancy-specific glycoprotein 1 and its identification as a novel Galectin-1 ligand. Glycobiology 30:11, pages 895-909.
Crossref
Dragana Robajac, Valerie Vanhooren, Romana Masnikosa, Željko Miković, Vesna Mandić, Claude Libert & Olgica Nedić. (2016) Preeclampsia transforms membrane N-glycome in human placenta. Experimental and Molecular Pathology 100:1, pages 26-30.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.